Prostate Cancer in Cisgender Gay and Bisexual Men and Trans Women
Channa A. Amarasekera, MD
Assistant Professor of Urology
Feinberg School of Medicine
Chicago, IL
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2022. All rights reserved.
Dr. Amarasekera is an Assistant Professor of Urology at Northwestern University Feinberg School of Medicine with a clinical focus on men’s health, sexual medicine, and reconstructive surgery. He has a special interest in Peyronie’s disease, erectile dysfunction, and prostate cancer survivorship. His research is dedicated to identifying and addressing urologic healthcare disparities faced by sexual minorities. He graduated summa cum laude from the University of Maryland with a degree in Cell Biology and Molecular Genetics and attended Harvard Medical School. He did his residency training at Northwestern.
Dr. Amarasekera is the director of the Gay and Bisexual Men’s Urology Program - the nation’s first urology clinic targeting the needs of gay and bisexual men. With Dr. Amarasekera`s leadership, this patient-centered program is designed to improve the urologic care experience, outcomes and quality of life for patients who were assigned male at birth (AMAB) and identify as gay or bisexual.
At the completion of this educational session, learners will:
1. Learn about the current clinical terminology used to identify sexual minority patients.
2. Know the unique impacts of prostate cancer on gay and bisexual men.
3. Understand how HIV infection influences prostate cancer screening and treatment.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. Braun (Course Director) has no relevant financial relationships to disclose.
- Dr. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Amarasekera (Presenter) has no relevant financial relationships to disclose. Dr. Amarasekera submitted their slides in advance for adequate peer review, and will support their presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Download Article PDF/Slides